Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 5971-5974, November 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, M.
Right arrow Articles by Yoshida, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, M.
Right arrow Articles by Yoshida, S.

Inhibition of Mammalian DNA Polymerases by Recombinant {alpha}-Interferon and {gamma}-Interferon1

Masao Tanaka2, Kiyoji Kimura and Shonen Yoshida

Hematological Disease Center, Nagoya National Hospital, Naka-ku [M. T., K. K.], and Institute for Disease Mechanism and Control, Nagoya University School of Medicine [S. Y.] Nagoya, Japan

Interferons (IFNs) have been shown to suppress the growth of both normal and malignant cells. We examined the effect of gene-cloned IFN-{alpha} and IFN-{gamma} on the in vitro activities of human, calf, or rat DNA polymerases. IFN-{alpha} strongly inhibited the reactions of DNA polymerase {alpha} and ß at apparent Ki values of 1.25 and 0.35 x 105 antiviral units/ml, respectively, but inhibited DNA polymerase {gamma} only slightly. IFN-{gamma} inhibited the reaction of DNA polymerase {alpha} more strongly (Ki, 1.2 x 104 units/ml) than IFN-{alpha}, but not that of DNA polymerase ß. On the other hand, neither IFN-{alpha} nor IFN-{gamma} inhibited the reactions of DNA polymerase I from Escherichia coli, Klenow fragment, T-4 DNA polymerase, and RNA polymerase. The fact that Ki values for IFN-{alpha} of DNA polymerase from calf thymus, human leukemic cells, and rat liver were similar suggests the absence of species specificity among animals with regard to the inhibition of DNA polymerases by IFNs. These results indicate that DNA polymerase may be one of the targets of the action of IFNs.

1 This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health and Welfare of Japan.

2 To whom requests for reprints should be addressed.

Received 12/17/86. Revised 6/ 5/87. Accepted 8/14/87.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A.-S.A. Ismail, C. J. Van Groeningen, A. Hardcastle, Q.-F. Ren, G. W. Aherne, F. Geoffroy, C. J. Allegra, and J. L. Grem.
Modulation of Fluorouracil Cytotoxicity by Interferon-alpha and -gamma
Mol. Pharmacol., February 1, 1998; 53(2): 252 - 261.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.